C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

FDA Grants Orphan Drug Designation to Omeros’ MASP-3 Inhibitor OMS906 for Treatment of Paroxysmal Nocturnal Hemoglobinuria

Saturday, July 30, 2022

Omeros Corporation today announced that OMS has received orphan drug designation from the US Food and Drug Administration FDA for the treatment of paroxysmal nocturnal hemoglobinuria PNH OMS targets mannanbinding lectinassociated serine protease MASP...

Dr. Reddy's Laboratories enters into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify® in the U.S.

Saturday, July 30, 2022

Dr Reddys Laboratories Ltd today announced that it has entered into a licensing agreement with Princeton New Jersey based Slayback Pharma LLC Slayback to acquire rights in Slaybacks Brimonidine Tartrate Ophthalmic Solution the private label equivale...

Astria Therapeutics Announces FDA Clearance of IND Application for STAR-0215, a Monoclonal Antibody Inhibitor of Plasma Kallikrein for Treatment of Hereditary Angioedema

Thursday, July 28, 2022

Astria Therapeutics Inc a biopharmaceutical company developing STAR for hereditary angioedema and focused on lifechanging therapies for rare and niche allergic and immunological diseases today announced the US Food and Drug Administration FDA clearan...

Tonix Pharmaceuticals Announces Collaboration with Kenya Medical Research Institute to Develop TNX-801 in Kenya as a Vaccine for the Prevention of Monkeypox and Smallpox Infection

Thursday, July 28, 2022

Tonix Pharmaceuticals Holding Corp a clinicalstage biopharmaceutical company today announced a collaboration with the Kenya Medical Research Institute KEMRI to plan seek regulatory approval for and conduct a Phase clinical study in Kenya to develop...

Sunshine Biopharma Increases Support For Anti-Coronavirus Collaborative Research With The University Of Arizona

Thursday, July 28, 2022

Sunshine Biopharma Inc a pharmaceutical company focused on the research development and commercialization of oncology and antiviral drugs today announced that it has agreed to provide additional resources to the University of Arizona R Ken Coit Colle...

Marinus Pharmaceuticals Announces U.S. Commercial Launch of ZTALMY® (ganaxolone) for Seizures Associated With CDKL5 Deficiency Disorder

Thursday, July 28, 2022

Marinus Pharmaceuticals Inc a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders today announced the US commercial launch of ZTALMY ganaxolone oral suspension CV for the treatment of seizures ass...

Gene Editing Market to reach USD 19.9 billion by 2030

Wednesday, July 27, 2022

Growing occurrence of genetic disorders and advances in healthcare technologies will fuel global gene editing market share Many developed and developing countries are witnessing a disturbing rise in rare disease cases According to the Cystic Fibrosis...

FDA Accepts Biogen’s New Drug Application and Grants Priority Review of Tofersen for a Rare, Genetic Form of ALS

Tuesday, July 26, 2022

Biogen Inc announced that the US Food and Drug Administration FDA has accepted a New Drug Application NDA for tofersen an investigational drug for superoxide dismutase SOD amyotrophic lateral sclerosis ALS The application has been granted priority r...

Cosmo and Sun Pharma Announce Territory Expansion of License and Supply Agreements for WINLEVI® to include Japan, Australia, New Zealand, Brazil, Mexico and Russia

Tuesday, July 26, 2022

Sun Pharmaceutical Industries Limited and Cassiopea a subsidiary of Cosmo Pharmaceuticals NV today announced the signing of addendums to the License and Supply Agreements for WINLEVI clascoterone cream expanding the territory to include Japan Austra...

SomaLogic acquires DNA nanotechnology leader Palamedrix to develop the next-generation SomaScan® Assay

Tuesday, July 26, 2022

SomaLogic a leader in AI datadriven proteomics technology today announced it entered into an agreement to acquire Palamedrix Inc an innovator in DNA nanotechnology Palamedrix provides deep scientific and engineering expertise miniaturization technolo...